2. Others
  3. Others
  4. Anticancer agent 31

Anticancer agent 31 is a 1,3-diphenylurea quinoxaline derivative, and a anticancer agent. Anticancer agent 31 exhibits antitumor acitvity by arresting cell cycle at S phase and inducing apoptosis.

For research use only. We do not sell to patients.

Anticancer agent 31 Chemical Structure

Anticancer agent 31 Chemical Structure

CAS No. : 2222930-72-3

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  
Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Anticancer agent 31 Related Antibodies

Top Publications Citing Use of Products

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Anticancer agent 31 is a 1,3-diphenylurea quinoxaline derivative, and a anticancer agent. Anticancer agent 31 exhibits antitumor acitvity by arresting cell cycle at S phase and inducing apoptosis[1].

In Vitro

Anticancer agent 31 (compound 2d) shows anticancer activity against human tumor cell lines (MGC-803, NCI-H460, T-24, HeLa, HepG2, and SMMC-7721) and displays lower cytotoxicity than 5-FU (HY-90006), Sorafenib.html" class="link-product" target="_blank">Sorafenib (HY-10201), and Cisplatin (HY-17394)[1].
Anticancer agent 31 (10, and 15 μM; 24 h) arrests cell cycle at S phase in MGC-803 cells, and induces tumor cells apoptosis[1].
Anticancer agent 31 (5, 10, and 15 μM; 24 h) reduces cell cycle regulatory protein CDK2, CDK4, cyclin A2, cyclin B1, and Apaf-1, anti-apoptotic protein Bcl-2; increases pro-apoptotic protein Bax protein level[1].
Anticancer agent 31 (5, 10 μM; 24 h) activates caspase-3 and caspase-9 by 73.6% and 65.3%, respectively; and also causes the loss of mitochondrial membrane potential (MMP) increase in JC-1 (HY-15534) detection[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Anticancer agent 31 Related Antibodies

Cell Cytotoxicity Assay[1]

Cell Line: Normal cell line: HL-7702 and six human tumor cell lines: MGC-803, NCI-H460, T-24, HeLa, HepG2, and SMMC-7721
Concentration:
Incubation Time:
Result: Inhibited human tumor cell with IC50s of 9 μM (MGC-803), 12.3 μM (HeLa), 13.3 μM (NCI-H460), 30.4 μM (HepG2), 17.6 μM (SMMC-7721), 27.5 μM (T-24), respectively. Showed lowe cytotoxicity with an IC50 value of 80.9 μM, higher than the IC50s of tumor cell cells.

Western Blot Analysis[1]

Cell Line: MGC-803
Concentration: 0, 5, 10, 15 μM
Incubation Time: 24 hours
Result: Decreased cell cycle regulatory protein (cyclin-dependent kinase (CDK)2, CDK4, cyclin A2, and cyclin B1) levels in a dose-dependent manner.
Suppressed anti-apoptotic protein Bcl-2 expression and up-regulated pro-apoptotic protein Bax level.

Apoptosis Analysis[1]

Cell Line: MGC-803
Concentration: 0, 5, 10, 15 μM
Incubation Time: 24 hours
Result: Caused MGC-803 cells arrest at S phase from 24.45% to 41.39% at 15 μM concentration.
Indicated that there was a interaction with DNA in the nucleus and affect DNA replication.
Increased the percentage of apoptotic tumor cells from 4.31% to 37.21%.

Immunofluorescence[1]

Cell Line: MGC-803
Concentration: 5, 10 μM
Incubation Time: 24 hours; JC-1 as the fluorescent probe
Result: Induced the loss of mitochondrial membrane potential (MMP) from 0.79% (control) to 37.4% (5 μM) and 81.4% (10 μM), respectively.
Molecular Weight

497.50

Formula

C28H21F2N5O2
CAS No.
SMILES

O=C(NC1=CC=CC(CNC2=NC3=CC(F)=C(C=C3N=C2)F)=C1)NC4=CC=C(C=C4)OC5=CC=CC=C5
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Anticancer agent 31 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Anticancer agent 312222930-72-3Anticancer agent31Anticancer agent-31Others1,3-diphenylurea quinoxalinederivativeantitumoranticancerarrest cell cycleHL-7702MGC-803NCI-H460T-24HeLaHepG2SMMC-7721Inhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Anticancer agent 31
Cat. No.:
HY-143302
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

English - EN (0 KB) Français - FR (0 KB) Deutsch - DE (0 KB) Norwegian - NO (0 KB) Español - ES (0 KB) Swedish - SV (0 KB)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.